← All stocks

INTEGRA LIFESCIENCES HOLDINGS CORP

IART Net selling
CIK 0000917520 #2363 in the set updated 18 Sep 2026
Bought (120 mo)
$4.55M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$332.61M
$0.00 on a plan · $85.51M straight out of an exercise
Sold at will
$247.10M
79 of 137 sales
Net
−$328.06M
−$242.55M against sales at will

By person

34 insiders · 150 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Tru St Partnership, L.P. entity
10% owner
$114.85M (9)
−$114.85M
8,515,930
$96.66M
−17.3%
CARUSO RICHARD E
10% owner
$101.32M (10)
−$101.32M
21,350,078
$242.32M
−7.4%
ESSIG STUART
President and CEO
$1.50M (1)
$52.55M (13) scheduled
−$51.05M
2,342,406
$26.59M
−11.5%
Arduini Peter J
President & CEO
$39.02M (14) scheduled
−$39.02M
216,713
$2.46M
+292.6%
Coleman Glenn
Executive Vice President & COO
$7.99M (19)
−$7.99M
34,622
$392.96K
+31.8%
DAVIS ROBERT T. JR.
EVP & President, TR&DT
$3.45M (6)
−$3.45M
66,387
$753.49K
+107.6%
Evoli Lisa
EVP & CHRO
$2.37M (17) scheduled
−$2.37M
21,260
$241.30K
+243.7%
HILL BARBARA B
Director
$1.95M (4)
+$1.95M
187,541
$2.13M
+441.8%
REUVERS DANIEL L.
CVP,PRES - CODMAN SPC SURGICAL
$1.66M (7) scheduled
−$1.66M
42,673
$484.34K
+128.7%
SCHADE CHRISTIAN S
Director
$1.64M (2) scheduled
−$1.64M
90,034
$1.02M
+244.6%
SULLIVAN JAMES M
Director
$1.54M (2) scheduled
−$1.54M
62,569
$710.16K
+14.8%
Murphy Raymond G.
Director
$1.16M (5)
−$1.16M
111,529
$1.27M
+24.4%
MOORADIAN JOHN
Corp VP, Global Ops & Supp Chn
$1.01M (5) scheduled
−$1.01M
17,542
$199.10K
+45.5%
McBreen Michael J.
EVP & Chief Commercial Officer
$964.02K (6)
−$964.02K
60,743
$689.43K
+153.4%
BRADLEY KEITH
Director
$861.26K (1) scheduled
−$861.26K
88,254
$1.00M
+167.0%
Schwartz Eric
EVP, Chief Legal Officer & Sec
$100.04K (1)
$797.11K (4)
−$697.08K
56,020
$635.83K
VINHAIS JOSEPH
Corp VP,Quality&Transformation
$498.64K (3)
−$498.64K
8,231
$93.42K
−4.5%
MOREL DONALD E JR
Director
$492.46K (2)
+$492.46K
55,753
$632.80K
+136.6%
Mosebrook Jeffrey
SVP, Fin & Princ Acct Officer
$427.23K (10)
−$427.23K
34,516
$391.76K
+377.1%
Burhop Kenneth
CORPVP,CHIEFSCIENTIFIC OFFICER
$425.84K (2) scheduled
−$425.84K
15,100
$171.39K
+150.7%
De Witte Jan
President & CEO
$299.99K (1)
+$299.99K
23,902
$271.29K
Ballintyn Rhonda Germany
Director
$108.40K (1)
+$108.40K
18,746
$212.77K
+1,083%
GRAVES JEFFREY A
Director
$102.15K (1)
+$102.15K
41,086
$466.33K
GORELICK RICHARD D.
Corp VP, Gen Counsel & Sec
$70.79K (2)
−$70.79K
25,752
$292.29K
+33.5%
Anderson Carrie L
Executive Vice President & CFO
57,811
$656.15K
Knight Lea Daniels
EVP & Chief Financial Officer
45,263
$513.74K
HOWELL LLOYD JR
Director
44,638
$506.64K
+31.4%
Clay Shaundra
Director
41,515
$471.20K
Lo Renee Wonlai
Director
35,743
$405.68K
Singh Harvinder
EVP & President, SS
35,422
$402.04K
OGRADY JUDITH
CorpVP,Global Reg.Affairs
24,276
$275.53K
+34.8%
Veillon-Berteloot Chantal
EVP & CHRO
20,772
$235.76K
Augusti Mark A
CVP,PRES-ORTHO & TISSUE TECH
7,962
$90.37K
−3.3%
Poul Mojdeh
President & CEO
0
$0.00

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
GRAVES JEFFREY A
5 Nov 2025
Director
Buy
9,000
$11.35
$102.15K
ESSIG STUART
23 May 2024
Exec. Chairman of the Board
Buy
52,641
$28.49
$1.50M
HILL BARBARA B
21 May 2024
Director
Buy indirect
36,350
$27.40
$995.82K
De Witte Jan
1 Jun 2023
President & CEO
Buy
7,792
$38.50
$299.99K
Schwartz Eric
1 Jun 2023
EVP, Chief Legal Officer & Sec
Buy
2,640
$37.89
$100.04K
Ballintyn Rhonda Germany
14 Mar 2019
Director
Buy
1,933
$56.08
$108.40K
HILL BARBARA B
5 Nov 2018
Director
Buy
3,705
$53.90
$199.68K
HILL BARBARA B
31 Oct 2017
Director
Buy
10,768
$46.66
$502.45K
MOREL DONALD E JR
4 Aug 2017
Director
Buy
7,500
$49.23
$369.23K
MOREL DONALD E JR
3 Aug 2017
Director
Buy
2,500
$49.29
$123.23K
HILL BARBARA B
1 Aug 2017
Director
Buy
5,050
$49.33
$249.11K

What was left out

Form 4 filings counted 451
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 58
Sales at will 79
Transactions with no price 0
Shares from compensation/vesting 4,452,042
Sales filed before the plan box existed 75
History held since 11 Oct 2016